Publicacións nas que colabora con JUANA MARIA GARCIA PEDRERO (24)

2024

  1. Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

    Molecular Cancer, Vol. 22, Núm. 1

  2. Chemo-Immunotherapy: A New Trend in Cancer Treatment

    Cancers, Vol. 15, Núm. 11

2022

  1. Pathobiological functions and clinical implications of annexin dysregulation in human cancers

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application

    Reviews of physiology, biochemistry and pharmacology, Vol. 181, pp. 375-427

2020

  1. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2019

  1. Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma

    Archives of Dermatological Research, Vol. 311, Núm. 5, pp. 369-376

  2. The novel role of SOX2 as an early predictor of cancer risk in patients with laryngeal precancerous lesions

    Cancers, Vol. 11, Núm. 3

  3. “The big sleep: Elucidating the sequence of events in the first hours of death to determine the postmortem interval”

    Science and Justice, Vol. 59, Núm. 4, pp. 418-424

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

  3. Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813

2017

  1. A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions

    Scientific Reports, Vol. 7, Núm. 1

  2. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b

    Scientific Reports, Vol. 7, Núm. 1

  3. Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells

    Oncotarget, Vol. 8, Núm. 8, pp. 13716-13729

  4. Dysregulation of miR-196b in head and neck cancers leads to pleiotropic effects in the tumor cells and surrounding stromal fibroblasts

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: Evidence for regulation by epigenetic mechanisms

    Scientific Reports, Vol. 6

2015

  1. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas

    Scientific Reports, Vol. 5

2012

  1. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: Pathobiological mechanisms and clinical implications

    Journal of Molecular Medicine, Vol. 90, Núm. 10, pp. 1173-1184

  2. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas

    Modern Pathology, Vol. 25, Núm. 8, pp. 1069-1078